Investing.com - Cyclo Therapeutics reported on Friday third quarter earnings that matched analysts' forecasts and revenue that was inline with expectations.
Cyclo Therapeutics announced earnings per share of $-0.37 on revenue of $618K. Analysts polled by Investing.com EPS of $-0.37 on revenue of $618K.
Cyclo Therapeutics 's are down 60% and is trading at $1.36 , still down 83.57% from its 52 week high of $8.28 set on Tuesday, November 16, 2021.
Cyclo Therapeutics shares gained 1.70% to trade at $1.36 in intra-day trade the report.
Cyclo Therapeutics follows other major Healthcare sector earnings this month
Cyclo Therapeutics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar